Cannabis Global (OTC: CBGL), a science-forward company developing CBD infusion technologies and products while investing in fast-growing segments of the cannabis industry, today announced an acceleration of its plans to expand operations in the cannabis sector in reaction to the significantly improved prospects for nationwide legalization of cannabis. According to the update, the strategic expansion will be conducted with Natural Plant Extract of California Inc (“NPE”). Cannabis Global recently acquired an 18.8% strategic investment stake in NPE, which holds a special Type 7 California cannabis manufacturing license, allowing for volatile extraction methodologies and cannabis product distribution anywhere in the state. “We are already seeing rapid expansion of cannabis legalization across the United States, with last week multiple states voting to legalize. With a new Biden Administration, we believe the winds of change toward probable federal de-scheduling and legalization are accelerating,” said CBGL CEO Arman Tabatabaei. “With a combination of our growing intellectual property portfolio and the continued expansion of our relationship in the licensed cannabis segment with NPE, nationwide cannabis legalization creates expanding opportunities for our company.”
To view the full press release, visit https://cnw.fm/TfMQD
About Cannabis Global Inc.
Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission, trading with the stock symbol CBGL. The company is an emerging force in cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. Cannabis Global has an actively growing portfolio of cannabis investments and intellectual property, having filed six provisional patents relative to the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel(TM) brand name. Cannabis Global launched its Project Varin early in 2020 to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and develop products based on this cannabinoid. For more information, visit the company’s website at www.CannabisGlobalInc.com.
NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/CBGL
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire is part of the InvestorBrandNetwork.